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A B S T R A C T
Background: Co-existence of hypertension is known in three quarter of Indian type 2 diabetics, this duo
having adverse additive effect on cardiovascular health including dysautonomia. Later can be measured
by simple 5 min heart rate variability (HRV) using simple electrocardiogram, which if reduced indicates
cardiac risk.
Objective: We compared HRV parameters between hypertensive and normotensive type 2 diabetics,
looking for signiﬁcant difference if any.
Materials and methods: 98 hypertensive and 40 normotensive type 2 diabetics treated as outpatients
were evaluated for disease control and risk stratiﬁcation. 5 min resting HRV was measured by Variowin
HR, software based instrument, using standard protocols to record time domain, frequency domain and
Poincare plot parameters. They were compared between groups for difference with p < 0.05 deﬁning
statistical signiﬁcance.
Results: Mean age was 56 and 51 years, duration 6 years and 4 years respectively in hypertensive (HT)
and normotensive (NT) group of type 2 diabetics, which did not signiﬁcantly differ in distribution of risk
factors. There was poor glycaemic control (one third only) in both groups and good pressure control in HT
group. Both groups revealed all reduced HRV parameters with signiﬁcant difference in-between only for
LF/HF ratio (1.29 in HT vs 2.61 in NT group).
Conclusion: Our ﬁndings of HRV suggest that in type 2 diabetics with poor glycaemic and good pressure
control, hypertension as a co-existing factor does not make signiﬁcant difference in cardiac
dysautonomia emphasizing residual risk despite antihypertensive treatment and need for early HRV
screening, strict glycaemic control and other interventions.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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India stands second globally in type 2 diabetes mellitus
(T2DM) with alarming future prediction1 and co-existence of
hypertension (HTN) and T2DM is in 75% cases.2 Both have a
threatening synergistic effect3 with majority of sub-optimal
disease control4,5 and same is evident in T2DM subjects of our
regions as per our previous study.6 Cardiac autonomic neuropa-
thy is common yet overlooked complication which contributes
to residual risk for cardiovascular morbidity and mortality.7
Heart rate variability (HRV), measured by simple 5 min* Corresponding author at: F1, Shivganga Appartments, Plot No. 164, Bhayani ni
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creativecommons.org/licenses/by-nc-nd/4.0/).recording provides reliable status of cardiac autonomic bal-
ance.8 Reduced HRV is seen in both HTN and T2DM individually
and known to be an independent risk factor for cardiovascular
health.9 But only few studies like Takahashi et al.10 have focused
their synergistic effect, perhaps none from India. Indian
hypertensives are very peculiar4 and we hypothesize to assess
the effect of coexisting hypertension on HRV in known type
2 diabetics.
2. Materials and methods
2.1. Study design
This case control study was conducted in the Department of
Medicine with the help of Department of Physiology, Government
Medical College, Bhavnagar, Gujarat, India during a period from
15th October 2014 to 15th January 2015.y of cardiac autonomic status by heart rate variability between
 diabetics, Indian Heart J. (2016), http://dx.doi.org/10.1016/
 India. This is an open access article under the CC BY-NC-ND license (http://
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After approval from the Institutional ethical Committee and
written informed consent from each subject, volunteers were
recruited for this study. Of total number of subjects that
attended the Out Door Clinic, all the adult subjects were
screened for presence of type 2 diabetes. Subjects coming to
clinic with record of treatment of diabetes were also included in
this screening for conﬁrmation. Of total number of patients with
type 2 diabetes, observed during the recruitment period
(n = 300), 138 patients were randomly selected for this study.
Sample size was calculated by software Raosoft (Raosoft, Inc.
free online software, Seattle, WA, USA). A sample of 138 subjects
for a population of 6 lakhs with 7.33% prevalence of type
2 diabetes mellitus in our region gave us 95% conﬁdence level,
leaving 5% margin of error.
2.3. Inclusion and exclusion criteria
We included type 2 diabetic patients, with minimum duration
of one year and known glycaemic control, aged 30–70 years, of
either sex, taking regular treatment (through chart review), not
taking insulin, ready for written consent.
Exclusion criteria were; those patients with less than one year
duration of diabetes (n = 12), taking irregular treatment of diabetes
(n = 18), age more than 70 years (n = 127), patients having cancer
(n = 0), chronic dysentery (n = 0), chronic renal failure (n = 3), type
1 diabetes (n = 9), on pace maker (n = 0), past history of
intervention, drug therapy inﬂuencing autonomic function
(n = 11) and non-volunteers (n = 1) were excluded.
2.4. Collection of data
All the data were collected by a personal interview by a
trained physician via validated questionnaires that included
symptoms of cardiac autonomic neuropathy, investigations
done, treatment received, salt, alcohol and tobacco intake and
physical activity
Speciﬁc emphasis was given to identify following 10 risk factors
including diabetes itself: (1) hypertension, (2) hyperlipidaemia, (3)
smoking, (4) cardiovascular disease (CVD), (5) family history, (6)
age > 52 years, (7) male gender, (8) fasting blood sugar (FBS)
>130 mg/dL, (9) body mass index (BMI) >25 kg/m2, (10) type
2 diabetes mellitus.
Salt intake was the sum of the salt used during preparation of
food and added at the table by each subject.11,12 Added ingestion
was from salt added to manufactured foods was taken into
account. The physician also measured body weight on each visit
independently in light under clothing to the nearest of 0.1 kg, after
removing shoes of the subjects. Height was measured without shoe
by standing close to scale.
After a 5-min rest, a blood pressure was recorded in a sitting
position, on the right arm with a standard mercury manometer.
Every subject had two readings, with the average of these
reading recorded as the resting blood pressure. To minimize
measurement errors, one individual was assigned to measure
blood pressure for all the subjects in both the groups. In
accordance with the WHO guidelines, if a blood pressure of
more than 140/90 mmHg was recorded, a repeat measurement
was obtained after a 5-min rest, with the subject in a supine
position.
Physical activity was assessed by a questionnaires detailing
occupational, household, and spare time physical activity. Seden-
tary lifestyle assessment was based on occupational or household
activity, along with spare time activity measures as reported
earlier.11 Alcohol and tobacco consumption were recorded byPlease cite this article in press as: Solanki JD, et al. Comparative stud
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j.ihj.2016.07.013questionnaires.12 Tobacco consumption was deﬁned as tobacco
intake, in any form, for example, chewing or smoking.12 Alcohol
intake was considered in presence of drinking of alcohol at least
once per week.12
2.5. Deﬁnition of disease control
Prehypertension is diagnosed in presence of a systolic pressure
from 120 to 139 mmHg or a diastolic pressure from 80 to
89 mmHg. Readings greater than or equal to 140/90 mmHg are
considered hypertension.
Hypertension was also diagnosed as per self-reported use of
medications and available records of treatment for high blood
pressure during the 2 weeks preceding the clinic examination.
Participants also brought to the examination all medications they
had taken in the preceding 2 weeks.
We deﬁned glycaemic control as per criteria laid by American
Diabetes Association 201413 and good glycaemic control was
deﬁned as (1) HbA1c  7 mg%, (2) FBS  126 mg% and (3)
PP2BS  180 mg%.
2.6. Measurement of HRV
The time domain variables and frequency domain variables
were measured and taken for comparison by window based
software VarioWin HR.14 Assessment of heart rate variability was
carried out between 8.30 and 12.00 am in an isolated examination
room. Patients were requested to avoid coffee, tea, cola drinks and
smoking for 12 h and alcoholic beverages for 24 h before
procedure. We recorded ECG for the analysis of beat-to-beat heart
rate variability after supine rest for at least 5 min while the subject
was in supine position and breathing freely. The ECG was recorded
from the precordial leads and transferred on-line to a microcom-
puter for the analysis of heart rate variability. Only stationary time
series of approximately 5-min durations free of arrhythmia and
artefacts were used.
2.7. HRV parameters
In time-domain analysis of HRV parameters included are RR
interval, standard deviation of all RR intervals (SDNN), the square
root of the mean of the sum of the squares of differences between
adjacent RR intervals (RMSSD), standard deviation of successive
differences (SDSD) and pNN50, which is the percentage of
consecutive RR intervals that differ by >50 ms.15
The frequency-domain analysis of HRV consisted of the power
of high frequency (HF), (0.15–0.40 Hz); low frequency (LF), (0.04–
0.15 Hz); and very low frequency (VLF), (below 0.04 Hz) power
ranges. LF and HF were presented also in normalized units and as a
ratio.15
Poincare plot analysis included SD1 and SD1 which are standard
deviation of RR interval along major and minor axis respectively.
Scatter index was represented as ratio of SD1 to SD2 which
reﬂected the HRV in a non-linear manner.
2.8. Statistical analysis
The data was transferred on Excel spreadsheet and descriptive
analysis was expressed as mean  standard deviation. All calcula-
tions were accomplished by Graph Pad in Stat 3 software (demo
version free software of GraphPad Software, Inc. California, USA). We
calculated the statistical signiﬁcance of difference in mean distribu-
tion of various parameters amongst various subgroups by Mann–
Whitney test or unpaired student t test for quantitative data and by
Fisher’s exact test for qualitative data. Difference was considered
statistically signiﬁcant with p < 0.05.y of cardiac autonomic status by heart rate variability between
 diabetics, Indian Heart J. (2016), http://dx.doi.org/10.1016/
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Two groups did not signiﬁcantly differ in gender distribution,
height, weight, BMI and glycaemic control. However, hypertensive
diabetics (HTDM) had older age (57 years vs 52 years, p = 0.005),
blood pressure (systolic 136 vs 124, diastolic 83 vs 79, mean 101 vs
94. p < 0.05 for all) and duration of type 2 diabetes (6 years vs
4 years, p = 0.018) as compared to normotensive ones (NTDM) yet
pressure control was comparatively good (half having normal
mean blood pressure) in former group (Table 1).
HTDM and NTDM groups had statistically insigniﬁcant differ-
ence of distribution of risk factors where high BMI, female gender,
older age, positive family history and poor glycaemic control were
present in large proportion of subjects in both groups (Table 2).
Comparison of time domain, frequency domain and non-linear
parameters of heart rate variability revealed that there is reduced
HRV in hypertensive (HTDM) and normotensive (NTDM) type 2
diabetics. Though reduced in both groups, NTDM group had
better proﬁle of frequency domain parameters than HTDM groupTable 1
Demographic and clinical characteristics of type 2 diabetic subjects under study (n = 13
General features HT group N
mean  SD m
Age (years) 57.07  8.36 5
Gender – male/female/total 47/51/98 2
Duration of DM (years) 6.21  5.38 3
Height (cm) 159.5  9.23 1
Weight (kg) 67.5  10.67 6
BMI (kg/m2) 26.63  4.59 2
Glycemic control – value mean  SD-HT 
1. HbA1c (mg%) 8.17  1.99 
2. FBS (mg%) 158.14  57.05 
3. PP2BS (mg%) 251.13  103.34 
Glycemic control – prevalence Number (%) 
1. HbA1c 15/39 (38.46%) 
2. FBS 27/71 (38%) 
3. PP2BS 23/75 (30.67%) 
Blood pressure control – value mean  SD 
1. SBP (mmHg) 136.22  19.2 
2. DBP (mmHg) 83.4  9.68 
3. MBP (mmHg) 101.01  11.95 
Blood pressure control – prevalence Number (%) 
1. SBP 66/98 (67%) 
2. DBP 80/98 (82%) 
3. MBP 49/98 (50%) 
* Indicates statistical signiﬁcance.
Abbreviations: HT, hypertensive; NT, normotensive; BMI, body mass index; HbA1c, glycos
SBP, systolic blood pressure; DBP, diastolic blood pressure; MBP, mean blood pressure
Table 2
Prevalence of various known risk factors for cardiovascular disease in hypertensive an
Risk factors Prevalence (number)
Hypertensive (n = 98) 
Present Absent 
1. Hyperlipidemia 23 75 
2. Smoking 13 85 
3. Alcohol 3 95 
4. Known heart disease 29 69 
5. Family history of DM 35 63 
6. Age > 52 yaers 68 30 
7. Female gender 51 47 
8. BMI > 25 kg/m2 58 40 
9. FBS > 126 mg% 44 54 
* Indicates statistical signiﬁcance.
Abbreviations: BMI, body mass index; FBS, fasting blood sugar.
Please cite this article in press as: Solanki JD, et al. Comparative stud
under-treatment normotensive and hypertensive known type 2
j.ihj.2016.07.013(LFnu – 283 ms vs 262 ms, HFnu – 360 ms vs 262 ms, LF:HF ratio
2.61 vs 1.29, p > 0.05 for all) although they had higher heart rate
(88 vs 83). Except for LF/HF ratio (p = 0.002) all parameters did not
differ between HTDM and NTDM groups (p > 0.05) (Table 3).
Similarly, NTDM subjects, like HTDM subjects had reduced
values but no signiﬁcantly better proﬁle of time domain HRV
parameters (SDNN 24 vs 26, RMSSD 20 vs 21, SDSD 18 vs 17, NN50
13 vs 9, Triangular HRV index 13 vs 9, p > 0.05 for all) (Table 3).
Similarly, comparison of HRV parameters based on Poincare
plotting revealed almost reduced but comparable results in NTDM
and HTDM group (SD1 14 vs 13, SD2 26 vs 25, scatter index 0.48 vs
0.52, p > 0.05 for all), with all lacking statistical signiﬁcance
(Table 3).
4. Discussion
Type 2 diabetes mellitus (T2DM) has reached epidemic
potential in India1 and the iceberg of hypertension (HTN) is
prevailing in nearly one out of three urban Indian.4 Co-existence of8).
T group HT vs NT Total
ean  SD p value mean  SD
1.61  9.61 0.005* 55.5  9.09
1/19/40 0.71 68/70/138
.97  4.05 0.018* 5.66  5.15
60.8  9.54 0.083 160.58 9.74
7.35  10.31 0.76 67.50  10.68
5.59  4.15 0.22 26.31  4.51
mean  SD-NT p value mean  SD
7.63  1.5 0.53 8.10  0.93
173.91  66.97 0.28 162.0  59.65
238.63  89.73 0.69 245.76  98.15
Number (%) p value Number (%)
3/6 (50%) 0.67 18/45 (20%)
7/23 (30.43%) 0.62 34/94 (37%)
9/30 (30%) 1 32/105 (30%)
mean  SD p value mean  SD
124.24  12.86 0.001* 132.52  18.36
78.83  6.51 0.009* 82.08  9.02
93.81  7.83 0.001* 93.87  24.40
Number (%) p value Number (%)
40/40 (100%) <0.0001* 106/138
40/40 (100%) 0.018* 120/138
40/40 (100%) <0.0001* 89/138
ylated haemoglobin A1c; FBS, fasting blood sugar; PP2BS, post prandial blood sugar;
.
d normotensive type 2 diabetics (absolute number and percentage).
Normotensive (n = 40) p value
Present Absent
4 36 0.09
9 31 0.203
2 38 0.62
9 31 0.52
10 30 0.24
19 21 0.02*
19 21 0.71
21 19 0.57
16 24 0.7
y of cardiac autonomic status by heart rate variability between
 diabetics, Indian Heart J. (2016), http://dx.doi.org/10.1016/
Table 3
Quantitative comparison of HRV parameters between normotensive and hyper-
tensive type 2 diabetics (mean  SD).
HRV parameter Hypertensive DM
(mean  SD)
Normotensive DM
(mean  SD)
p value
VLF power 407.85  376.41 504.33  565.78 0.81
LF power 262.1  586.48 283.31  313.59 0.52
HF power 262.68  572.58 360.12  807.49 0.7
LF(nu) 0.56  0.18 0.61  0.20 0.18
HF(nu) 0.43  0.174 0.39  0.20 0.2
Maximum LF 0.074  0.081 0.26  1.13 0.99
Maximum HF 0.28  0.087 0.26  0.086 0.13
LF/HF ratio 1.29  1.29 2.61  2.29 0.0002*
Heart rate 82.9  14.98 88  15.25 0.082
Mode value 731.09  135.71 701.65  138.16 0.26
Triangular HRV index 6.27  6.89 5.84  3.36 0.79
SDNN 26.07  34.1 24.32  17.42 0.83
RMSSD 21.084  25.26 20.12  19.91 0.98
SDSD 16.99  20.5 17.46  21.32 0.96
NN50 count 9.06  24.71 13.87  25.3 0.43
PNN50% 3.42  10.82 4.21  9.1 0.49
R–R interval 744.18  135.58 705.8  139.5 0.15
SD1 13.12  13.13 14.29  15.21 0.88
SD2 25.36  13 26.23  17.38 0.62
Scatter index 0.48 0.27 0.52  0.33 0.68
* Indicates statistical signiﬁcance.
Abbreviations: VLF, very low frequency; LF, low frequency; HF, high frequency; nu,
normalized unit; SDNN, standard deviation of NN interval; RMSSD, root mean
square of standard deviation; SDSD, standard deviation of standard deviation; SD1,
standard deviation 1 along major axis; SD2, standard deviation 2 along minor axis.
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population as per our previous study, wherein former seems
because of later so that both should be screened and tackled
simultaneously.
Diabetic autonomic neuropathy may affect many systems
throughout the body, including the cardiovascular, gastrointestinal
and genitourinary systems, with a variety of adverse outcomes
including cardiovascular deaths due to silent myocardial ischae-
mia and cardiovascular autonomic neuropathy.16 Cardiovascular
autonomic neuropathy may cause abnormalities in heart rate
control as well as in central and peripheral vascular dynamics that
are linked to decreased heart rate variability, postural hypotension,
exercise intolerance, enhanced intraoperative cardiovascular
mortality, increased incidence of asymptomatic ischaemia, myo-
cardial infarction, and decreased likelihood of survival after
myocardial infarction, and thus increased overall mortality and
morbidity in diabetes. Presence of hypertension further enhances
the autonomic dysfunction.
We found poor glycaemic control, comparatively good blood
pressure control and lack of use of life style modiﬁcation
interventions in our middle aged study group. We found that
type 2 daibetics with or without hypertension had in general
reduced total power, reduced time domain and frequency domain
parameters of HRV. This is well supported by previous studies done
in type 2 diabetics with3 or without17–20 hypertension. This can be
explained by high mean age in mid-50s,21mean duration of disease
5 years8,15 and glycaemic control7,13 which was optimum in just
one third. T2DM and CAN are linked by inﬂammatory mediators22
and better glycaemic control is proven beneﬁcial fact.8 Yet in
Indian context, strict glycaemic control is not promptly practiced
and HbA1c, the gold standard of disease control is not available to
the most,1 just like our cases and our previous study in same
population.6 Five minute HRV recording can provide equal
information as 24 h HRV.23 Reduced HRV is either due to damage
to cardiac autonomic nerves by hyperglycaemia of T2DM or by
sympathetic over activity like one of HTN,24 so we hypothetized
better HRV proﬁle in normotensive type 2 diabetics than
hypertensive ones.Please cite this article in press as: Solanki JD, et al. Comparative stud
under-treatment normotensive and hypertensive known type 2
j.ihj.2016.07.013We found no difference in overall cardiac autonomic status in
hypertensive diabetics as compared to normotensive diabetics.
This is contradictory to few other western studies,3 but Indian
scenario of these two diseases could be different. CAN is seen even
before inception of T2DM25 and a recent study of HRV screening
suggests that diabetics can be differentiated from normal controls
on the basis of reduced HRV.26 Similarly, T2DM itself could be the
fore-runner of HTN wherein anti-hypertensive could cure only one
affected variable–blood pressure. The same is indicated in our
study, as mean age of hypertensives was 51 against that of
normotensive diabetics 57 years and mean duration of T2DM was
4 years in normotensive vs 6 years in hypertensives. However, LF/
HF ratio which signiﬁes sympatho-vagal balance was signiﬁcantly
higher in normotensives compared to hypertensives though a
recent study shows this ratio to be of less signiﬁcance.27 Result can
be due to fact that hypertensive T2DM patients were offered
calcium channel blockers or angiotensin converting enzyme
inhibitor, both of which have anti-sympathetic effect that checks
sympathetic over-activity.28,29 Beneﬁt of anti-hypertensive thera-
py can be evident if there is reduced resting heart rate30 that was
not much different in either group, being in 80s. Beta blockers have
deﬁnite beneﬁt as a drug restoring autonomic balance30 but it is
usually not given as monotherapy and was not given to any of our
hypertensives. This may also explain lack of signiﬁcant HRV
difference between diabetics taking or not taking other anti-
hypertensive monotherapy. Resting heart rate has a prognostic
value as a risk factor and its higher value indicates poor control of
cardiovascular risk.31
Autonomic functions are determined by sympathetic and
parasympathetic nerves, the pituitary and pineal glands and the
suprachiasmatic nucleus.32 Western diet, exercise, tobacco and
alcoholism can also cause autonomic dysfunction which may be
associated with sympathetic activation predisposing atheroscle-
rosis, end-organ damage, and hypertension.33–36 It seems that diet
and lifestyle factors can also inﬂuence autonomic function and
may have inﬂuence on HRV. Experimental studies indicate that
high-fat-induced weight gain in rats elevates plasma leptin at 1–3
days after the onset of calorie-dense diets, and that diet-induced
overfeeding may increase sympathetic activity within 1 week after
the onset of the regimen. An unpublished part of this same work37
has revealed no difference of HRV proﬁle in type 2 diabetics with or
without glycaemic or pressure control indicating that residual
cardiac risk remains despite control of these two parameters and
cardiac autonomic status must be screened and targeted for better
cardiovascular outcome. CAN cannot be overlooked in type
2 diabetics, having poor glycaemic control as major risk that can
be reduced by early diagnosis and strict glycaemic control and
residual risk can be further reduced by life style interventions like
weight reduction and exercise.38 HRV screening is suggested to be
used in all type 2 diabetics39 and it can help in primary prevention
of abnormal aftermath of CAN in T2DM. HRV can be used even by
family physicians who are treating majority of type 2 diabetics and
who can offer beneﬁt of HRV screening to type 2 diabetics at the
inception of disease and put appropriate preventive remarks in
treatment as a whole.
5. Limitation of study
There were few limitations which are needed to be mentioned.
First, the cross-sectional nature of study and moderate sample
size warrants prospective vertical study with larger sample in
subjects starting with baseline measurement followed serially.
Present form of study cannot establish cause effect relationship.
Second, we used ﬁve minute HRV that reveals only short term
changes in cardiac autonomic status and 24 h HRV is required to
further consolidate the results. Third, presence of confoundingy of cardiac autonomic status by heart rate variability between
 diabetics, Indian Heart J. (2016), http://dx.doi.org/10.1016/
J.D. Solanki et al. / Indian Heart Journal xxx (2016) xxx–xxx 5
G Model
IHJ-1017; No. of Pages 5factors, absence of control and euglycaemic hypertensives, and
reliance on manually measured blood pressure were also limiting
our study. Still it underscored relatively less impact of co-existing
hypertension on cardiac autonomic status in type 2 diabetics and
need of optimum control of later.
6. Conclusion
We found reduced HRV parameters in type 2 diabetics having
poor glycaemic control which was not signiﬁcantly affected by
presence of its co-existing aftermath hypertension, though
controlled and use of antihypertensive treatment excluding beta
blockers. It suggests that reduced HRV can precede type 2 diabetes
which itself is a fore-runner of hypertension and cardiac
autonomic balance is not affected much by good pressure control
but can be by good glycaemic control which along with residual
cardiac risk despite it, are still left unexplored.
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